Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Principia Biopharma patents proteasome subunit beta type-8 and/or beta type-9 inhibitors

June 7, 2019

Senju Pharmaceutical synthesizes new PAC1 and/or VPAC1 and/or VPAC2 receptor ligands

June 6, 2019

CCR5 mutation leads to increased mortality

June 4, 2019

FOX-115 improves endurance of motor performances in aged mice

May 20, 2019

Vasopressin V2 receptor antagonists disclosed by Toa Eiyo

May 17, 2019

Boehringer Ingelheim identifies new Bruton tyrosine kinase inhibitors

May 3, 2019

Bristol-Myers Squibb synthesizes new galectin 3 inhibitors

April 30, 2019

Nihon Pharmaceutical and Niigata University present liver integrated bone marrow-derived stem cells

April 18, 2019

Galapagos initiates first-in-human trial of GLPG-3121

April 11, 2019

Aduro BioTech discovers cyclic GMP-AMP synthase inhibitors

April 9, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 21, 2025.
Makary’s vision for slimmed-down US FDA somewhat reassuring
BioWorld
Nearly three weeks into the job, U.S. FDA Commissioner Marty Makary provided a comprehensive overview of his vision for the much-reduced agency, even as he’s...
Ouch! Tariffs hit med tech harder than expected
BioWorld MedTech
First quarter earnings reports from Johnson & Johnson and Abbott Laboratories provided some surprising insights into the likely hit med-tech companies will...
Dupixent bounces back in treating hives with FDA approval
BioWorld
The U.S. FDA issued a complete response letter in October 2023 for Dupixent (dupilumab) in treating chronic hives but has now approved the monoclonal antibody for...